Personalized medicine's ragged edge

Hastings Center Report

Volumn 40, Issue 5, 2010, Pages 16-18

  Fleck, Leonard M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DOSE RESPONSE; DRUG APPROVAL; DRUG THERAPY; FOOD AND DRUG ADMINISTRATION; HUMAN; PERSONALIZED MEDICINE; UNITED STATES;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG APPROVAL; DRUG THERAPY; HUMANS; INDIVIDUALIZED MEDICINE; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 77957876459     PISSN: 00930334     EISSN: 1552146X     Source Type: Journal    
DOI: 10.1353/hcr.2010.0005     Document Type: Review

References (1)

1. B.P. Schneider et al., " Association of Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor-2 Genetic Polymorphisms with Outcome in a Trial of Pacilitaxel Compared with Pacilitaxel Plus Bevacizumab in Advanced Breast Cancer: ECOG 2100," Journal of Clinical Oncology 26 (2008): 4672-78.